nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—ABCB1—kidney cancer	0.239	1	CbGaD
Amsacrine—TOP2A—Doxorubicin—kidney cancer	0.068	0.148	CbGbCtD
Amsacrine—ABCB1—Temsirolimus—kidney cancer	0.0492	0.107	CbGbCtD
Amsacrine—KCNH2—Sunitinib—kidney cancer	0.0486	0.106	CbGbCtD
Amsacrine—CYP2D6—Temsirolimus—kidney cancer	0.0463	0.101	CbGbCtD
Amsacrine—ABCB1—Pazopanib—kidney cancer	0.0258	0.0562	CbGbCtD
Amsacrine—CYP2D6—Pazopanib—kidney cancer	0.0243	0.053	CbGbCtD
Amsacrine—ABCB1—Dactinomycin—kidney cancer	0.0236	0.0514	CbGbCtD
Amsacrine—ABCB1—Gemcitabine—kidney cancer	0.0187	0.0406	CbGbCtD
Amsacrine—ABCB1—Erlotinib—kidney cancer	0.0184	0.0401	CbGbCtD
Amsacrine—CYP2D6—Erlotinib—kidney cancer	0.0174	0.0378	CbGbCtD
Amsacrine—ABCB1—Paclitaxel—kidney cancer	0.0169	0.0367	CbGbCtD
Amsacrine—ABCB1—Sorafenib—kidney cancer	0.015	0.0326	CbGbCtD
Amsacrine—ABCB1—Vinblastine—kidney cancer	0.0148	0.0322	CbGbCtD
Amsacrine—ABCB1—Vincristine—kidney cancer	0.0145	0.0317	CbGbCtD
Amsacrine—CYP2D6—Sorafenib—kidney cancer	0.0141	0.0307	CbGbCtD
Amsacrine—CYP2D6—Vinblastine—kidney cancer	0.0139	0.0303	CbGbCtD
Amsacrine—ABCB1—Sunitinib—kidney cancer	0.0121	0.0264	CbGbCtD
Amsacrine—ABCB1—Doxorubicin—kidney cancer	0.00909	0.0198	CbGbCtD
Amsacrine—CYP2D6—Doxorubicin—kidney cancer	0.00856	0.0186	CbGbCtD
Amsacrine—NCOA3—renal system—kidney cancer	0.00188	0.138	CbGeAlD
Amsacrine—NCOA3—kidney—kidney cancer	0.00182	0.133	CbGeAlD
Amsacrine—NCOA3—cortex of kidney—kidney cancer	0.00177	0.13	CbGeAlD
Amsacrine—NCOA3—gonad—kidney cancer	0.00169	0.124	CbGeAlD
Amsacrine—NCOA3—cardiac atrium—kidney cancer	0.00168	0.124	CbGeAlD
Amsacrine—CYP2D6—urine—kidney cancer	0.00154	0.113	CbGeAlD
Amsacrine—NCOA3—Idarubicin—Doxorubicin—kidney cancer	0.000956	0.204	CbGdCrCtD
Amsacrine—TOP2A—Docetaxel—Paclitaxel—kidney cancer	0.000849	0.181	CbGdCrCtD
Amsacrine—KCNH2—renal system—kidney cancer	0.000618	0.0454	CbGeAlD
Amsacrine—KCNH2—cardiac atrium—kidney cancer	0.000554	0.0406	CbGeAlD
Amsacrine—TOP2A—Vindesine—Vincristine—kidney cancer	0.000432	0.0919	CbGdCrCtD
Amsacrine—TOP2A—Vindesine—Vinblastine—kidney cancer	0.000432	0.0919	CbGdCrCtD
Amsacrine—TOP2A—Gefitinib—Erlotinib—kidney cancer	0.000407	0.0866	CbGdCrCtD
Amsacrine—CYP2D6—renal system—kidney cancer	0.000377	0.0277	CbGeAlD
Amsacrine—CYP2D6—kidney—kidney cancer	0.000365	0.0267	CbGeAlD
Amsacrine—ABCB1—nephron tubule—kidney cancer	0.000298	0.0219	CbGeAlD
Amsacrine—TOP2A—Vinorelbine—Vincristine—kidney cancer	0.000272	0.058	CbGdCrCtD
Amsacrine—TOP2A—Vinorelbine—Vinblastine—kidney cancer	0.000272	0.058	CbGdCrCtD
Amsacrine—ABCB1—renal system—kidney cancer	0.000271	0.0199	CbGeAlD
Amsacrine—ABCB1—kidney—kidney cancer	0.000262	0.0192	CbGeAlD
Amsacrine—ABCB1—cortex of kidney—kidney cancer	0.000255	0.0187	CbGeAlD
Amsacrine—ABCB1—gonad—kidney cancer	0.000243	0.0178	CbGeAlD
Amsacrine—TOP2A—Vincristine—Vinblastine—kidney cancer	0.000233	0.0496	CbGdCrCtD
Amsacrine—TOP2A—Vinblastine—Vincristine—kidney cancer	0.000187	0.0399	CbGdCrCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000173	0.00287	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—kidney cancer	0.000172	0.00285	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000171	0.00282	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—APRT—kidney cancer	0.000168	0.00278	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—FH—kidney cancer	0.000168	0.00278	CbGpPWpGaD
Amsacrine—CYP2D6—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000167	0.00277	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—JUN—kidney cancer	0.000167	0.00276	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000164	0.00271	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000163	0.0027	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000163	0.0027	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—PTEN—kidney cancer	0.000161	0.00266	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GPC3—kidney cancer	0.000158	0.00261	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	0.000154	0.00255	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CA2—kidney cancer	0.000154	0.00254	CbGpPWpGaD
Amsacrine—TOP2A—Cytarabine—Gemcitabine—kidney cancer	0.000153	0.0326	CbGdCrCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000153	0.00252	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ALAD—kidney cancer	0.00015	0.00247	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—EGR1—kidney cancer	0.000147	0.00242	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ST3GAL2—kidney cancer	0.000146	0.00242	CbGpPWpGaD
Amsacrine—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.000145	0.000648	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000145	0.000648	CcSEcCtD
Amsacrine—Asthenia—Erlotinib—kidney cancer	0.000144	0.000646	CcSEcCtD
Amsacrine—Mental disorder—Paclitaxel—kidney cancer	0.000144	0.000646	CcSEcCtD
Amsacrine—Thrombocytopenia—Vincristine—kidney cancer	0.000144	0.000645	CcSEcCtD
Amsacrine—Urticaria—Sorafenib—kidney cancer	0.000144	0.000643	CcSEcCtD
Amsacrine—Haematuria—Capecitabine—kidney cancer	0.000143	0.000642	CcSEcCtD
Amsacrine—Malnutrition—Paclitaxel—kidney cancer	0.000143	0.000641	CcSEcCtD
Amsacrine—Decreased appetite—Dactinomycin—kidney cancer	0.000143	0.000641	CcSEcCtD
Amsacrine—Diarrhoea—Vinblastine—kidney cancer	0.000143	0.000641	CcSEcCtD
Amsacrine—Abdominal pain—Sorafenib—kidney cancer	0.000143	0.00064	CcSEcCtD
Amsacrine—Body temperature increased—Sorafenib—kidney cancer	0.000143	0.00064	CcSEcCtD
Amsacrine—NCOA3—Metabolism—ALDH1A1—kidney cancer	0.000143	0.00236	CbGpPWpGaD
Amsacrine—Diarrhoea—Everolimus—kidney cancer	0.000142	0.000638	CcSEcCtD
Amsacrine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000142	0.000637	CcSEcCtD
Amsacrine—Hepatobiliary disease—Capecitabine—kidney cancer	0.000142	0.000637	CcSEcCtD
Amsacrine—Fatigue—Dactinomycin—kidney cancer	0.000142	0.000636	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—MYC—kidney cancer	0.000142	0.00234	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—ACHE—kidney cancer	0.000141	0.00233	CbGpPWpGaD
Amsacrine—Pain—Dactinomycin—kidney cancer	0.000141	0.000631	CcSEcCtD
Amsacrine—Vascular purpura—Doxorubicin—kidney cancer	0.000141	0.00063	CcSEcCtD
Amsacrine—Agranulocytosis—Capecitabine—kidney cancer	0.00014	0.000629	CcSEcCtD
Amsacrine—Anorexia—Vincristine—kidney cancer	0.00014	0.000628	CcSEcCtD
Amsacrine—Hepatic failure—Doxorubicin—kidney cancer	0.00014	0.000627	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	0.000139	0.00229	CbGpPWpGaD
Amsacrine—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000139	0.000621	CcSEcCtD
Amsacrine—Infection—Gemcitabine—kidney cancer	0.000139	0.000621	CcSEcCtD
Amsacrine—Dizziness—Vinblastine—kidney cancer	0.000138	0.000619	CcSEcCtD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	0.000138	0.00228	CbGpPWpGaD
Amsacrine—Dizziness—Everolimus—kidney cancer	0.000138	0.000617	CcSEcCtD
Amsacrine—Body temperature increased—Sunitinib—kidney cancer	0.000137	0.000616	CcSEcCtD
Amsacrine—Abdominal pain—Sunitinib—kidney cancer	0.000137	0.000616	CcSEcCtD
Amsacrine—Diarrhoea—Erlotinib—kidney cancer	0.000137	0.000616	CcSEcCtD
Amsacrine—Hypotension—Vincristine—kidney cancer	0.000137	0.000616	CcSEcCtD
Amsacrine—Bradycardia—Capecitabine—kidney cancer	0.000137	0.000616	CcSEcCtD
Amsacrine—NCOA3—Metabolism—SLC5A3—kidney cancer	0.000137	0.00226	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PGK1—kidney cancer	0.000137	0.00226	CbGpPWpGaD
Amsacrine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000137	0.000612	CcSEcCtD
Amsacrine—Feeling abnormal—Dactinomycin—kidney cancer	0.000136	0.000608	CcSEcCtD
Amsacrine—Haemoglobin—Capecitabine—kidney cancer	0.000136	0.000608	CcSEcCtD
Amsacrine—Skin disorder—Gemcitabine—kidney cancer	0.000136	0.000607	CcSEcCtD
Amsacrine—Hepatitis—Capecitabine—kidney cancer	0.000135	0.000605	CcSEcCtD
Amsacrine—Haemorrhage—Capecitabine—kidney cancer	0.000135	0.000605	CcSEcCtD
Amsacrine—Vision blurred—Paclitaxel—kidney cancer	0.000135	0.000605	CcSEcCtD
Amsacrine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000135	0.000603	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—IL13—kidney cancer	0.000134	0.00222	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—LDHB—kidney cancer	0.000134	0.00222	CbGpPWpGaD
Amsacrine—Hypoaesthesia—Capecitabine—kidney cancer	0.000134	0.000602	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000134	0.00222	CbGpPWpGaD
Amsacrine—Urinary tract disorder—Capecitabine—kidney cancer	0.000133	0.000597	CcSEcCtD
Amsacrine—Hypersensitivity—Sorafenib—kidney cancer	0.000133	0.000597	CcSEcCtD
Amsacrine—Anorexia—Gemcitabine—kidney cancer	0.000133	0.000596	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000133	0.0022	CbGpPWpGaD
Amsacrine—Vomiting—Vinblastine—kidney cancer	0.000133	0.000596	CcSEcCtD
Amsacrine—Dizziness—Erlotinib—kidney cancer	0.000133	0.000595	CcSEcCtD
Amsacrine—Connective tissue disorder—Capecitabine—kidney cancer	0.000133	0.000594	CcSEcCtD
Amsacrine—Vomiting—Everolimus—kidney cancer	0.000132	0.000593	CcSEcCtD
Amsacrine—Anaemia—Paclitaxel—kidney cancer	0.000132	0.000593	CcSEcCtD
Amsacrine—Urethral disorder—Capecitabine—kidney cancer	0.000132	0.000593	CcSEcCtD
Amsacrine—Paraesthesia—Vincristine—kidney cancer	0.000132	0.000592	CcSEcCtD
Amsacrine—TOP2A—Daunorubicin—Doxorubicin—kidney cancer	0.000131	0.028	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Doxorubicin—kidney cancer	0.000131	0.028	CbGdCrCtD
Amsacrine—TOP2A—Epirubicin—Doxorubicin—kidney cancer	0.000131	0.028	CbGdCrCtD
Amsacrine—Rash—Everolimus—kidney cancer	0.000131	0.000588	CcSEcCtD
Amsacrine—Dermatitis—Everolimus—kidney cancer	0.000131	0.000588	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—MAPK1—kidney cancer	0.000131	0.00217	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—KRAS—kidney cancer	0.000131	0.00216	CbGpPWpGaD
Amsacrine—Headache—Vinblastine—kidney cancer	0.000131	0.000587	CcSEcCtD
Amsacrine—Purpura—Doxorubicin—kidney cancer	0.00013	0.000585	CcSEcCtD
Amsacrine—Headache—Everolimus—kidney cancer	0.00013	0.000585	CcSEcCtD
Amsacrine—Hypotension—Gemcitabine—kidney cancer	0.00013	0.000584	CcSEcCtD
Amsacrine—Body temperature increased—Dactinomycin—kidney cancer	0.00013	0.000583	CcSEcCtD
Amsacrine—Abdominal pain—Dactinomycin—kidney cancer	0.00013	0.000583	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.00013	0.00215	CbGpPWpGaD
Amsacrine—Asthenia—Sorafenib—kidney cancer	0.00013	0.000581	CcSEcCtD
Amsacrine—Lethargy—Doxorubicin—kidney cancer	0.000128	0.000575	CcSEcCtD
Amsacrine—Leukopenia—Paclitaxel—kidney cancer	0.000128	0.000574	CcSEcCtD
Amsacrine—Hypersensitivity—Sunitinib—kidney cancer	0.000128	0.000574	CcSEcCtD
Amsacrine—Decreased appetite—Vincristine—kidney cancer	0.000128	0.000573	CcSEcCtD
Amsacrine—Vomiting—Erlotinib—kidney cancer	0.000128	0.000572	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000127	0.000569	CcSEcCtD
Amsacrine—Fatigue—Vincristine—kidney cancer	0.000127	0.000568	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	0.000127	0.00209	CbGpPWpGaD
Amsacrine—Rash—Erlotinib—kidney cancer	0.000127	0.000568	CcSEcCtD
Amsacrine—Dermatitis—Erlotinib—kidney cancer	0.000127	0.000567	CcSEcCtD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	0.000126	0.00209	CbGpPWpGaD
Amsacrine—Headache—Erlotinib—kidney cancer	0.000126	0.000564	CcSEcCtD
Amsacrine—Pain—Vincristine—kidney cancer	0.000126	0.000564	CcSEcCtD
Amsacrine—Paraesthesia—Gemcitabine—kidney cancer	0.000125	0.000561	CcSEcCtD
Amsacrine—Cardiac disorder—Capecitabine—kidney cancer	0.000125	0.000561	CcSEcCtD
Amsacrine—Asthenia—Sunitinib—kidney cancer	0.000125	0.000559	CcSEcCtD
Amsacrine—Dyspnoea—Gemcitabine—kidney cancer	0.000124	0.000557	CcSEcCtD
Amsacrine—Nausea—Vinblastine—kidney cancer	0.000124	0.000556	CcSEcCtD
Amsacrine—Convulsion—Paclitaxel—kidney cancer	0.000124	0.000556	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—KRAS—kidney cancer	0.000124	0.00205	CbGpPWpGaD
Amsacrine—Affect lability—Doxorubicin—kidney cancer	0.000124	0.000555	CcSEcCtD
Amsacrine—Nausea—Everolimus—kidney cancer	0.000124	0.000554	CcSEcCtD
Amsacrine—Diarrhoea—Sorafenib—kidney cancer	0.000124	0.000554	CcSEcCtD
Amsacrine—KCNH2—Neuronal System—BCHE—kidney cancer	0.000123	0.00203	CbGpPWpGaD
Amsacrine—Angiopathy—Capecitabine—kidney cancer	0.000122	0.000549	CcSEcCtD
Amsacrine—Mediastinal disorder—Capecitabine—kidney cancer	0.000122	0.000545	CcSEcCtD
Amsacrine—Decreased appetite—Gemcitabine—kidney cancer	0.000121	0.000544	CcSEcCtD
Amsacrine—Hypersensitivity—Dactinomycin—kidney cancer	0.000121	0.000544	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000121	0.000542	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000121	0.00199	CbGpPWpGaD
Amsacrine—Arrhythmia—Capecitabine—kidney cancer	0.000121	0.00054	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00012	0.00054	CcSEcCtD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	0.00012	0.00199	CbGpPWpGaD
Amsacrine—Fatigue—Gemcitabine—kidney cancer	0.00012	0.000539	CcSEcCtD
Amsacrine—Gastrointestinal pain—Vincristine—kidney cancer	0.00012	0.000539	CcSEcCtD
Amsacrine—Dizziness—Sorafenib—kidney cancer	0.000119	0.000536	CcSEcCtD
Amsacrine—Pain—Gemcitabine—kidney cancer	0.000119	0.000535	CcSEcCtD
Amsacrine—Nausea—Erlotinib—kidney cancer	0.000119	0.000535	CcSEcCtD
Amsacrine—Alopecia—Capecitabine—kidney cancer	0.000119	0.000534	CcSEcCtD
Amsacrine—Mood swings—Doxorubicin—kidney cancer	0.000119	0.000534	CcSEcCtD
Amsacrine—Diarrhoea—Sunitinib—kidney cancer	0.000119	0.000533	CcSEcCtD
Amsacrine—Mental disorder—Capecitabine—kidney cancer	0.000118	0.00053	CcSEcCtD
Amsacrine—Asthenia—Dactinomycin—kidney cancer	0.000118	0.000529	CcSEcCtD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000118	0.00195	CbGpPWpGaD
Amsacrine—Confusional state—Paclitaxel—kidney cancer	0.000118	0.000528	CcSEcCtD
Amsacrine—Blood creatinine increased—Doxorubicin—kidney cancer	0.000118	0.000528	CcSEcCtD
Amsacrine—Malnutrition—Capecitabine—kidney cancer	0.000117	0.000526	CcSEcCtD
Amsacrine—NCOA3—Metabolism—CA9—kidney cancer	0.000116	0.00192	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—TP53—kidney cancer	0.000116	0.00192	CbGpPWpGaD
Amsacrine—Body temperature increased—Vincristine—kidney cancer	0.000116	0.000521	CcSEcCtD
Amsacrine—Abdominal pain—Vincristine—kidney cancer	0.000116	0.000521	CcSEcCtD
Amsacrine—Infection—Paclitaxel—kidney cancer	0.000116	0.00052	CcSEcCtD
Amsacrine—Dizziness—Sunitinib—kidney cancer	0.000115	0.000515	CcSEcCtD
Amsacrine—Feeling abnormal—Gemcitabine—kidney cancer	0.000115	0.000515	CcSEcCtD
Amsacrine—Vomiting—Sorafenib—kidney cancer	0.000115	0.000515	CcSEcCtD
Amsacrine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000114	0.000513	CcSEcCtD
Amsacrine—Tachycardia—Paclitaxel—kidney cancer	0.000114	0.000511	CcSEcCtD
Amsacrine—Rash—Sorafenib—kidney cancer	0.000114	0.000511	CcSEcCtD
Amsacrine—Dermatitis—Sorafenib—kidney cancer	0.000114	0.00051	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000114	0.00188	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—ALDH1A1—kidney cancer	0.000114	0.00188	CbGpPWpGaD
Amsacrine—Skin disorder—Paclitaxel—kidney cancer	0.000113	0.000509	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000113	0.000507	CcSEcCtD
Amsacrine—Headache—Sorafenib—kidney cancer	0.000113	0.000507	CcSEcCtD
Amsacrine—Diarrhoea—Dactinomycin—kidney cancer	0.000113	0.000505	CcSEcCtD
Amsacrine—Anorexia—Paclitaxel—kidney cancer	0.000111	0.000499	CcSEcCtD
Amsacrine—Vision blurred—Capecitabine—kidney cancer	0.000111	0.000496	CcSEcCtD
Amsacrine—Vomiting—Sunitinib—kidney cancer	0.000111	0.000495	CcSEcCtD
Amsacrine—Body temperature increased—Gemcitabine—kidney cancer	0.00011	0.000494	CcSEcCtD
Amsacrine—TOP2A—Azacitidine—Gemcitabine—kidney cancer	0.00011	0.0234	CbGdCrCtD
Amsacrine—Rash—Sunitinib—kidney cancer	0.00011	0.000491	CcSEcCtD
Amsacrine—Dermatitis—Sunitinib—kidney cancer	0.00011	0.000491	CcSEcCtD
Amsacrine—Hypotension—Paclitaxel—kidney cancer	0.000109	0.000489	CcSEcCtD
Amsacrine—Headache—Sunitinib—kidney cancer	0.000109	0.000488	CcSEcCtD
Amsacrine—Dysphagia—Doxorubicin—kidney cancer	0.000109	0.000487	CcSEcCtD
Amsacrine—Anaemia—Capecitabine—kidney cancer	0.000109	0.000487	CcSEcCtD
Amsacrine—Hypersensitivity—Vincristine—kidney cancer	0.000108	0.000486	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—KDR—kidney cancer	0.000108	0.00179	CbGpPWpGaD
Amsacrine—Nausea—Sorafenib—kidney cancer	0.000107	0.000481	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—MET—kidney cancer	0.000106	0.00175	CbGpPWpGaD
Amsacrine—Asthenia—Vincristine—kidney cancer	0.000106	0.000473	CcSEcCtD
Amsacrine—Leukopenia—Capecitabine—kidney cancer	0.000105	0.000471	CcSEcCtD
Amsacrine—Paraesthesia—Paclitaxel—kidney cancer	0.000105	0.00047	CcSEcCtD
Amsacrine—Vomiting—Dactinomycin—kidney cancer	0.000105	0.000469	CcSEcCtD
Amsacrine—Dyspnoea—Paclitaxel—kidney cancer	0.000104	0.000467	CcSEcCtD
Amsacrine—Rash—Dactinomycin—kidney cancer	0.000104	0.000465	CcSEcCtD
Amsacrine—Nausea—Sunitinib—kidney cancer	0.000103	0.000463	CcSEcCtD
Amsacrine—Pancytopenia—Doxorubicin—kidney cancer	0.000103	0.000463	CcSEcCtD
Amsacrine—Decreased appetite—Paclitaxel—kidney cancer	0.000102	0.000455	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000101	0.000452	CcSEcCtD
Amsacrine—Fatigue—Paclitaxel—kidney cancer	0.000101	0.000451	CcSEcCtD
Amsacrine—Diarrhoea—Vincristine—kidney cancer	0.000101	0.000451	CcSEcCtD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	0.0001	0.00166	CbGpPWpGaD
Amsacrine—Asthenia—Gemcitabine—kidney cancer	0.0001	0.000449	CcSEcCtD
Amsacrine—Pain—Paclitaxel—kidney cancer	9.99e-05	0.000448	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	9.93e-05	0.000445	CcSEcCtD
Amsacrine—NCOA3—Metabolism—CRABP1—kidney cancer	9.9e-05	0.00164	CbGpPWpGaD
Amsacrine—Weight increased—Doxorubicin—kidney cancer	9.89e-05	0.000443	CcSEcCtD
Amsacrine—Weight decreased—Doxorubicin—kidney cancer	9.83e-05	0.000441	CcSEcCtD
Amsacrine—Nausea—Dactinomycin—kidney cancer	9.78e-05	0.000438	CcSEcCtD
Amsacrine—Dizziness—Vincristine—kidney cancer	9.73e-05	0.000436	CcSEcCtD
Amsacrine—Infestation—Doxorubicin—kidney cancer	9.69e-05	0.000434	CcSEcCtD
Amsacrine—Infestation NOS—Doxorubicin—kidney cancer	9.69e-05	0.000434	CcSEcCtD
Amsacrine—Confusional state—Capecitabine—kidney cancer	9.67e-05	0.000433	CcSEcCtD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	9.66e-05	0.0016	CbGpPWpGaD
Amsacrine—Feeling abnormal—Paclitaxel—kidney cancer	9.63e-05	0.000431	CcSEcCtD
Amsacrine—Gastrointestinal pain—Paclitaxel—kidney cancer	9.55e-05	0.000428	CcSEcCtD
Amsacrine—Diarrhoea—Gemcitabine—kidney cancer	9.55e-05	0.000428	CcSEcCtD
Amsacrine—Renal failure—Doxorubicin—kidney cancer	9.52e-05	0.000427	CcSEcCtD
Amsacrine—Infection—Capecitabine—kidney cancer	9.52e-05	0.000427	CcSEcCtD
Amsacrine—Jaundice—Doxorubicin—kidney cancer	9.44e-05	0.000423	CcSEcCtD
Amsacrine—Stomatitis—Doxorubicin—kidney cancer	9.44e-05	0.000423	CcSEcCtD
Amsacrine—Thrombocytopenia—Capecitabine—kidney cancer	9.39e-05	0.000421	CcSEcCtD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	9.36e-05	0.00155	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	9.36e-05	0.00155	CbGpPWpGaD
Amsacrine—Tachycardia—Capecitabine—kidney cancer	9.36e-05	0.000419	CcSEcCtD
Amsacrine—Vomiting—Vincristine—kidney cancer	9.35e-05	0.000419	CcSEcCtD
Amsacrine—Skin disorder—Capecitabine—kidney cancer	9.31e-05	0.000417	CcSEcCtD
Amsacrine—Urticaria—Paclitaxel—kidney cancer	9.28e-05	0.000416	CcSEcCtD
Amsacrine—Rash—Vincristine—kidney cancer	9.27e-05	0.000416	CcSEcCtD
Amsacrine—Dermatitis—Vincristine—kidney cancer	9.26e-05	0.000415	CcSEcCtD
Amsacrine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	9.24e-05	0.00153	CbGpPWpGaD
Amsacrine—Haematuria—Doxorubicin—kidney cancer	9.24e-05	0.000414	CcSEcCtD
Amsacrine—Abdominal pain—Paclitaxel—kidney cancer	9.23e-05	0.000414	CcSEcCtD
Amsacrine—Body temperature increased—Paclitaxel—kidney cancer	9.23e-05	0.000414	CcSEcCtD
Amsacrine—Headache—Vincristine—kidney cancer	9.21e-05	0.000413	CcSEcCtD
Amsacrine—NCOA3—Metabolism—ITPR2—kidney cancer	9.2e-05	0.00152	CbGpPWpGaD
Amsacrine—Hepatobiliary disease—Doxorubicin—kidney cancer	9.16e-05	0.000411	CcSEcCtD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—kidney cancer	9.15e-05	0.00151	CbGpPWpGaD
Amsacrine—Anorexia—Capecitabine—kidney cancer	9.14e-05	0.00041	CcSEcCtD
Amsacrine—Agranulocytosis—Doxorubicin—kidney cancer	9.04e-05	0.000405	CcSEcCtD
Amsacrine—Hypotension—Capecitabine—kidney cancer	8.96e-05	0.000401	CcSEcCtD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	8.88e-05	0.00147	CbGpPWpGaD
Amsacrine—Vomiting—Gemcitabine—kidney cancer	8.87e-05	0.000398	CcSEcCtD
Amsacrine—Bradycardia—Doxorubicin—kidney cancer	8.85e-05	0.000397	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—PSMD7—kidney cancer	8.8e-05	0.00145	CbGpPWpGaD
Amsacrine—Rash—Gemcitabine—kidney cancer	8.8e-05	0.000394	CcSEcCtD
Amsacrine—Dermatitis—Gemcitabine—kidney cancer	8.79e-05	0.000394	CcSEcCtD
Amsacrine—Haemoglobin—Doxorubicin—kidney cancer	8.74e-05	0.000392	CcSEcCtD
Amsacrine—Headache—Gemcitabine—kidney cancer	8.74e-05	0.000392	CcSEcCtD
Amsacrine—Nausea—Vincristine—kidney cancer	8.74e-05	0.000392	CcSEcCtD
Amsacrine—Haemorrhage—Doxorubicin—kidney cancer	8.7e-05	0.00039	CcSEcCtD
Amsacrine—Hepatitis—Doxorubicin—kidney cancer	8.7e-05	0.00039	CcSEcCtD
Amsacrine—Hypoaesthesia—Doxorubicin—kidney cancer	8.65e-05	0.000388	CcSEcCtD
Amsacrine—Paraesthesia—Capecitabine—kidney cancer	8.61e-05	0.000386	CcSEcCtD
Amsacrine—Hypersensitivity—Paclitaxel—kidney cancer	8.61e-05	0.000386	CcSEcCtD
Amsacrine—Urinary tract disorder—Doxorubicin—kidney cancer	8.59e-05	0.000385	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—AURKA—kidney cancer	8.56e-05	0.00142	CbGpPWpGaD
Amsacrine—Connective tissue disorder—Doxorubicin—kidney cancer	8.55e-05	0.000383	CcSEcCtD
Amsacrine—Dyspnoea—Capecitabine—kidney cancer	8.55e-05	0.000383	CcSEcCtD
Amsacrine—Urethral disorder—Doxorubicin—kidney cancer	8.53e-05	0.000382	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.49e-05	0.0014	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CCND1—kidney cancer	8.47e-05	0.0014	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ACHE—kidney cancer	8.39e-05	0.00139	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTT1—kidney cancer	8.39e-05	0.00139	CbGpPWpGaD
Amsacrine—Asthenia—Paclitaxel—kidney cancer	8.38e-05	0.000376	CcSEcCtD
Amsacrine—Decreased appetite—Capecitabine—kidney cancer	8.33e-05	0.000373	CcSEcCtD
Amsacrine—Nausea—Gemcitabine—kidney cancer	8.29e-05	0.000371	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Capecitabine—kidney cancer	8.28e-05	0.000371	CcSEcCtD
Amsacrine—Fatigue—Capecitabine—kidney cancer	8.26e-05	0.00037	CcSEcCtD
Amsacrine—Pain—Capecitabine—kidney cancer	8.2e-05	0.000367	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	8.19e-05	0.00135	CbGpPWpGaD
Amsacrine—Cardiac disorder—Doxorubicin—kidney cancer	8.07e-05	0.000362	CcSEcCtD
Amsacrine—Diarrhoea—Paclitaxel—kidney cancer	7.99e-05	0.000358	CcSEcCtD
Amsacrine—NCOA3—Metabolism—SCARB1—kidney cancer	7.95e-05	0.00131	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	7.93e-05	0.00131	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	7.9e-05	0.00131	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	7.9e-05	0.00131	CbGpPWpGaD
Amsacrine—Feeling abnormal—Capecitabine—kidney cancer	7.9e-05	0.000354	CcSEcCtD
Amsacrine—Angiopathy—Doxorubicin—kidney cancer	7.89e-05	0.000354	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—PSMD7—kidney cancer	7.87e-05	0.0013	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS1—kidney cancer	7.87e-05	0.0013	CbGpPWpGaD
Amsacrine—Gastrointestinal pain—Capecitabine—kidney cancer	7.84e-05	0.000351	CcSEcCtD
Amsacrine—Mediastinal disorder—Doxorubicin—kidney cancer	7.84e-05	0.000351	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—RAF1—kidney cancer	7.83e-05	0.00129	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—RELA—kidney cancer	7.8e-05	0.00129	CbGpPWpGaD
Amsacrine—Arrhythmia—Doxorubicin—kidney cancer	7.77e-05	0.000348	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—ERBB2—kidney cancer	7.75e-05	0.00128	CbGpPWpGaD
Amsacrine—Dizziness—Paclitaxel—kidney cancer	7.72e-05	0.000346	CcSEcCtD
Amsacrine—NCOA3—Metabolism—PSMD7—kidney cancer	7.71e-05	0.00127	CbGpPWpGaD
Amsacrine—Alopecia—Doxorubicin—kidney cancer	7.69e-05	0.000344	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—AURKA—kidney cancer	7.66e-05	0.00127	CbGpPWpGaD
Amsacrine—Mental disorder—Doxorubicin—kidney cancer	7.62e-05	0.000342	CcSEcCtD
Amsacrine—Urticaria—Capecitabine—kidney cancer	7.62e-05	0.000341	CcSEcCtD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	7.59e-05	0.00125	CbGpPWpGaD
Amsacrine—Body temperature increased—Capecitabine—kidney cancer	7.58e-05	0.00034	CcSEcCtD
Amsacrine—Abdominal pain—Capecitabine—kidney cancer	7.58e-05	0.00034	CcSEcCtD
Amsacrine—Malnutrition—Doxorubicin—kidney cancer	7.57e-05	0.000339	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	7.49e-05	0.00124	CbGpPWpGaD
Amsacrine—Vomiting—Paclitaxel—kidney cancer	7.43e-05	0.000333	CcSEcCtD
Amsacrine—Rash—Paclitaxel—kidney cancer	7.37e-05	0.00033	CcSEcCtD
Amsacrine—Dermatitis—Paclitaxel—kidney cancer	7.36e-05	0.00033	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—RYR1—kidney cancer	7.35e-05	0.00121	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	7.35e-05	0.00121	CbGpPWpGaD
Amsacrine—Headache—Paclitaxel—kidney cancer	7.32e-05	0.000328	CcSEcCtD
Amsacrine—NCOA3—Metabolism—BCHE—kidney cancer	7.31e-05	0.00121	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—JUN—kidney cancer	7.28e-05	0.0012	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	7.27e-05	0.0012	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—SLC5A5—kidney cancer	7.22e-05	0.00119	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	7.22e-05	0.00119	CbGpPWpGaD
Amsacrine—Vision blurred—Doxorubicin—kidney cancer	7.14e-05	0.00032	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	7.11e-05	0.00117	CbGpPWpGaD
Amsacrine—Hypersensitivity—Capecitabine—kidney cancer	7.06e-05	0.000317	CcSEcCtD
Amsacrine—Anaemia—Doxorubicin—kidney cancer	7e-05	0.000314	CcSEcCtD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.98e-05	0.00115	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—SLC2A1—kidney cancer	6.98e-05	0.00115	CbGpPWpGaD
Amsacrine—Nausea—Paclitaxel—kidney cancer	6.94e-05	0.000311	CcSEcCtD
Amsacrine—Asthenia—Capecitabine—kidney cancer	6.88e-05	0.000308	CcSEcCtD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—MYC—kidney cancer	6.8e-05	0.00112	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—CTNNB1—kidney cancer	6.78e-05	0.00112	CbGpPWpGaD
Amsacrine—Leukopenia—Doxorubicin—kidney cancer	6.78e-05	0.000304	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.77e-05	0.00112	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	6.73e-05	0.00111	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTT1—kidney cancer	6.68e-05	0.0011	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	6.58e-05	0.00109	CbGpPWpGaD
Amsacrine—Convulsion—Doxorubicin—kidney cancer	6.56e-05	0.000294	CcSEcCtD
Amsacrine—Diarrhoea—Capecitabine—kidney cancer	6.56e-05	0.000294	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	6.52e-05	0.00108	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2B—kidney cancer	6.43e-05	0.00106	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	6.42e-05	0.00106	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	6.41e-05	0.00106	CbGpPWpGaD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.4e-05	0.000287	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	6.36e-05	0.00105	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—kidney cancer	6.36e-05	0.00105	CbGpPWpGaD
Amsacrine—Dizziness—Capecitabine—kidney cancer	6.34e-05	0.000284	CcSEcCtD
Amsacrine—KCNH2—Neuronal System—BRAF—kidney cancer	6.27e-05	0.00104	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—PTGS1—kidney cancer	6.26e-05	0.00103	CbGpPWpGaD
Amsacrine—Confusional state—Doxorubicin—kidney cancer	6.23e-05	0.000279	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	6.2e-05	0.00102	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—JUN—kidney cancer	6.15e-05	0.00102	CbGpPWpGaD
Amsacrine—Infection—Doxorubicin—kidney cancer	6.14e-05	0.000275	CcSEcCtD
Amsacrine—Vomiting—Capecitabine—kidney cancer	6.09e-05	0.000273	CcSEcCtD
Amsacrine—Thrombocytopenia—Doxorubicin—kidney cancer	6.05e-05	0.000271	CcSEcCtD
Amsacrine—Rash—Capecitabine—kidney cancer	6.04e-05	0.000271	CcSEcCtD
Amsacrine—Dermatitis—Capecitabine—kidney cancer	6.04e-05	0.000271	CcSEcCtD
Amsacrine—Tachycardia—Doxorubicin—kidney cancer	6.03e-05	0.00027	CcSEcCtD
Amsacrine—Headache—Capecitabine—kidney cancer	6.01e-05	0.000269	CcSEcCtD
Amsacrine—Skin disorder—Doxorubicin—kidney cancer	6e-05	0.000269	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	5.99e-05	0.00099	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—VEGFA—kidney cancer	5.97e-05	0.000987	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—PTEN—kidney cancer	5.95e-05	0.000983	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.9e-05	0.000975	CbGpPWpGaD
Amsacrine—Anorexia—Doxorubicin—kidney cancer	5.89e-05	0.000264	CcSEcCtD
Amsacrine—NCOA3—Metabolism—GSTP1—kidney cancer	5.82e-05	0.000962	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—BRCA2—kidney cancer	5.8e-05	0.000959	CbGpPWpGaD
Amsacrine—Hypotension—Doxorubicin—kidney cancer	5.77e-05	0.000259	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—CDKN2B—kidney cancer	5.75e-05	0.000951	CbGpPWpGaD
Amsacrine—Nausea—Capecitabine—kidney cancer	5.69e-05	0.000255	CcSEcCtD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.66e-05	0.000935	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MAPK3—kidney cancer	5.65e-05	0.000933	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	5.6e-05	0.000925	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—BIRC5—kidney cancer	5.55e-05	0.000917	CbGpPWpGaD
Amsacrine—Paraesthesia—Doxorubicin—kidney cancer	5.55e-05	0.000249	CcSEcCtD
Amsacrine—Dyspnoea—Doxorubicin—kidney cancer	5.51e-05	0.000247	CcSEcCtD
Amsacrine—NCOA3—Metabolism—ABCB1—kidney cancer	5.51e-05	0.00091	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	5.38e-05	0.000888	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	5.38e-05	0.000888	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MAPK1—kidney cancer	5.37e-05	0.000888	CbGpPWpGaD
Amsacrine—Decreased appetite—Doxorubicin—kidney cancer	5.37e-05	0.000241	CcSEcCtD
Amsacrine—NCOA3—Metabolism—GSTM1—kidney cancer	5.35e-05	0.000884	CbGpPWpGaD
Amsacrine—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.33e-05	0.000239	CcSEcCtD
Amsacrine—Fatigue—Doxorubicin—kidney cancer	5.33e-05	0.000239	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	5.29e-05	0.000875	CbGpPWpGaD
Amsacrine—Pain—Doxorubicin—kidney cancer	5.28e-05	0.000237	CcSEcCtD
Amsacrine—KCNH2—Neuronal System—RAF1—kidney cancer	5.24e-05	0.000866	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	5.15e-05	0.000851	CbGpPWpGaD
Amsacrine—Feeling abnormal—Doxorubicin—kidney cancer	5.09e-05	0.000228	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—KRAS—kidney cancer	5.07e-05	0.000839	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP1A1—kidney cancer	5.07e-05	0.000838	CbGpPWpGaD
Amsacrine—Gastrointestinal pain—Doxorubicin—kidney cancer	5.05e-05	0.000226	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	5.04e-05	0.000833	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	5.04e-05	0.000832	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	5.03e-05	0.000831	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—BIRC5—kidney cancer	4.96e-05	0.00082	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	4.94e-05	0.000816	CbGpPWpGaD
Amsacrine—Urticaria—Doxorubicin—kidney cancer	4.91e-05	0.00022	CcSEcCtD
Amsacrine—Abdominal pain—Doxorubicin—kidney cancer	4.88e-05	0.000219	CcSEcCtD
Amsacrine—Body temperature increased—Doxorubicin—kidney cancer	4.88e-05	0.000219	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.76e-05	0.000786	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTP1—kidney cancer	4.63e-05	0.000765	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	4.56e-05	0.000754	CbGpPWpGaD
Amsacrine—Hypersensitivity—Doxorubicin—kidney cancer	4.55e-05	0.000204	CcSEcCtD
Amsacrine—Asthenia—Doxorubicin—kidney cancer	4.43e-05	0.000199	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	4.41e-05	0.00073	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL2—kidney cancer	4.39e-05	0.000726	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	4.38e-05	0.000723	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	4.37e-05	0.000723	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	4.31e-05	0.000713	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTM1—kidney cancer	4.25e-05	0.000703	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.23e-05	0.000699	CbGpPWpGaD
Amsacrine—Diarrhoea—Doxorubicin—kidney cancer	4.23e-05	0.000189	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	4.22e-05	0.000698	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	4.22e-05	0.000698	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	4.22e-05	0.000698	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	4.19e-05	0.000693	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.16e-05	0.000688	CbGpPWpGaD
Amsacrine—Dizziness—Doxorubicin—kidney cancer	4.09e-05	0.000183	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—kidney cancer	4.06e-05	0.000671	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	4.03e-05	0.000666	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	3.98e-05	0.000657	CbGpPWpGaD
Amsacrine—Vomiting—Doxorubicin—kidney cancer	3.93e-05	0.000176	CcSEcCtD
Amsacrine—Rash—Doxorubicin—kidney cancer	3.9e-05	0.000175	CcSEcCtD
Amsacrine—Dermatitis—Doxorubicin—kidney cancer	3.89e-05	0.000174	CcSEcCtD
Amsacrine—Headache—Doxorubicin—kidney cancer	3.87e-05	0.000173	CcSEcCtD
Amsacrine—NCOA3—Metabolism—POMC—kidney cancer	3.78e-05	0.000625	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ACY1—kidney cancer	3.76e-05	0.000622	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—kidney cancer	3.73e-05	0.000617	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2A—kidney cancer	3.68e-05	0.000608	CbGpPWpGaD
Amsacrine—Nausea—Doxorubicin—kidney cancer	3.67e-05	0.000165	CcSEcCtD
Amsacrine—KCNH2—Neuronal System—MAPK1—kidney cancer	3.59e-05	0.000594	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ACY1—kidney cancer	3.55e-05	0.000586	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN2A—kidney cancer	3.29e-05	0.000544	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	3.26e-05	0.000538	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PDHB—kidney cancer	3.2e-05	0.000529	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CCND1—kidney cancer	3.11e-05	0.000514	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	3.08e-05	0.000509	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PDHB—kidney cancer	3.02e-05	0.000498	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS2—kidney cancer	3.01e-05	0.000498	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CCBL1—kidney cancer	3.01e-05	0.000497	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—POMC—kidney cancer	3.01e-05	0.000497	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN1B—kidney cancer	2.91e-05	0.000481	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CCBL1—kidney cancer	2.84e-05	0.000469	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CCND1—kidney cancer	2.78e-05	0.000459	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTEN—kidney cancer	2.63e-05	0.000434	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPAT—kidney cancer	2.61e-05	0.000431	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GLIPR1—kidney cancer	2.61e-05	0.000431	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MAPK3—kidney cancer	2.56e-05	0.000424	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MYC—kidney cancer	2.49e-05	0.000412	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.46e-05	0.000406	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPAT—kidney cancer	2.46e-05	0.000406	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MAPK1—kidney cancer	2.44e-05	0.000403	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—FH—kidney cancer	2.43e-05	0.000401	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APRT—kidney cancer	2.43e-05	0.000401	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.42e-05	0.0004	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.39e-05	0.000395	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.34e-05	0.000387	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MAPK3—kidney cancer	2.29e-05	0.000379	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—FH—kidney cancer	2.29e-05	0.000378	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APRT—kidney cancer	2.29e-05	0.000378	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GPC3—kidney cancer	2.28e-05	0.000377	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MYC—kidney cancer	2.23e-05	0.000368	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.23e-05	0.000368	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CA2—kidney cancer	2.22e-05	0.000367	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.22e-05	0.000366	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MAPK1—kidney cancer	2.18e-05	0.00036	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALAD—kidney cancer	2.16e-05	0.000357	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.15e-05	0.000355	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GPC3—kidney cancer	2.15e-05	0.000355	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.11e-05	0.000349	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ST3GAL2—kidney cancer	2.11e-05	0.000349	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.11e-05	0.000349	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.09e-05	0.000346	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CA2—kidney cancer	2.09e-05	0.000345	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALDH1A1—kidney cancer	2.06e-05	0.000341	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.04e-05	0.000337	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALAD—kidney cancer	2.04e-05	0.000337	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.99e-05	0.000329	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC5A3—kidney cancer	1.98e-05	0.000327	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PGK1—kidney cancer	1.98e-05	0.000327	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.94e-05	0.000321	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LDHB—kidney cancer	1.94e-05	0.00032	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.86e-05	0.000308	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PGK1—kidney cancer	1.86e-05	0.000308	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CA—kidney cancer	1.85e-05	0.000306	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.84e-05	0.000305	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—kidney cancer	1.83e-05	0.000303	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LDHB—kidney cancer	1.83e-05	0.000302	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.74e-05	0.000288	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.7e-05	0.00028	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CA9—kidney cancer	1.68e-05	0.000278	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.66e-05	0.000274	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CA9—kidney cancer	1.58e-05	0.000262	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.57e-05	0.000259	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.44e-05	0.000238	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CRABP1—kidney cancer	1.43e-05	0.000236	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.39e-05	0.00023	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CRABP1—kidney cancer	1.35e-05	0.000223	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ITPR2—kidney cancer	1.33e-05	0.00022	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ITPR2—kidney cancer	1.25e-05	0.000207	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ACHE—kidney cancer	1.21e-05	0.0002	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTT1—kidney cancer	1.21e-05	0.0002	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SCARB1—kidney cancer	1.15e-05	0.00019	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTT1—kidney cancer	1.14e-05	0.000189	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ACHE—kidney cancer	1.14e-05	0.000189	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS1—kidney cancer	1.14e-05	0.000188	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PSMD7—kidney cancer	1.11e-05	0.000184	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SCARB1—kidney cancer	1.08e-05	0.000179	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS1—kidney cancer	1.07e-05	0.000177	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—BCHE—kidney cancer	1.06e-05	0.000174	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PSMD7—kidney cancer	1.05e-05	0.000173	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC5A5—kidney cancer	1.04e-05	0.000172	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC2A1—kidney cancer	1.01e-05	0.000166	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—BCHE—kidney cancer	9.95e-06	0.000164	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC5A5—kidney cancer	9.83e-06	0.000162	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	9.6e-06	0.000159	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC2A1—kidney cancer	9.49e-06	0.000157	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTP1—kidney cancer	8.4e-06	0.000139	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTP1—kidney cancer	7.91e-06	0.000131	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTM1—kidney cancer	7.72e-06	0.000128	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCB1—kidney cancer	7.49e-06	0.000124	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP1A1—kidney cancer	7.32e-06	0.000121	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTM1—kidney cancer	7.27e-06	0.00012	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP1A1—kidney cancer	6.89e-06	0.000114	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—POMC—kidney cancer	5.46e-06	9.02e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—POMC—kidney cancer	5.14e-06	8.5e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS2—kidney cancer	4.35e-06	7.19e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS2—kidney cancer	4.1e-06	6.78e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTEN—kidney cancer	3.79e-06	6.27e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTEN—kidney cancer	3.58e-06	5.91e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CA—kidney cancer	2.68e-06	4.42e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.52e-06	4.17e-05	CbGpPWpGaD
